Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > ¾ÏÄ¡·á > ¹Ì±¹ÀÇ ¾ÏÀ» À§ÇÑ Ã¼¿ÜÁø´Ü (IVD) ½ÃÀå
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4556)
°¨¿°Áúȯ (322)
°ñÁúȯ Ä¡·á (48)
´ç´¢º´ (164)
¹é½Å (171)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (49)
ºñó¹æ ÀǾàǰ (149)
¼öÀÇÇÐ (18)
½Å°æÁúȯ (180)
½Å¾à°³¹ß (1333)
¾ÏÄ¡·á (857)
¾à¹°Àü´Þ (179)
ÀǾàǰ ±ÔÁ¦È¯°æ (108)
Á¤½ÅÁúȯ (89)
Á¦³×¸¯ ÀǾàǰ (117)
Á¦¾àȸ»çºÐ¼® (490)
󹿾à (128)
½ÃÀ庸°í¼­

¹Ì±¹ÀÇ ¾ÏÀ» À§ÇÑ Ã¼¿ÜÁø´Ü (IVD) ½ÃÀå

U.S. Cancer In-Vitro Diagnostics Markets

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2006³â 09¿ù »óǰÄÚµå 45069
ÆäÀÌÁö Á¤º¸
°¡°Ý
US $ 6,000 £Ü 6,813,000 Web Access (Regional License)
US $ 6,500 £Ü 7,380,700 Hard Copy & Web Access (Regional License)


Frost & Sullivan ¿¡¼­ 2006³â 09¿ù ¿¡ ¹ßÇàÇÑ ¡¸¹Ì±¹ÀÇ ¾ÏÀ» À§ÇÑ Ã¼¿ÜÁø´Ü (IVD) ½ÃÀ塹 º¸°í¼­´Â US $6,000 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.

Çѱ۸ñÂ÷

´Ù¾çÇÑ ÃÖ÷´Ü»ê¾÷ÀÇ Àü·«ÀûÁ¶»ç¸¦ Àü¹®À¸·Î ÇϰíÀÖ´Â ¹Ì±¹ÀÇ ¸®¼­Ä¡È¸»ç Frost & Sullivan (º»»ç : ÅØ»ç½ºÁÖ) ¿¡¼­ ¹Ì±¹ÀÇ ¾ÏÀ» À§ÇÑ Ã¼¿ÜÁø´Ü ½ÃÀå¿¡ °üÇÏ¿© »ó¼¼È÷ Á¶»ç¤ýºÐ¼®ÇÑ Á¶»çº¸°í¼­ "U.S. Cancer In-Vitro Diagnostics Markets"¸¦ ¹ßÇàÇÏ¿´½À´Ï´Ù.

¹Ì±¹ÀÇ ¾ÏÀ» À§ÇÑ Ã¼¿ÜÁø´Ü½ÃÀå ÀüüÀÇ °³¿ä ¹× µ¿Çâ°ú ÇÔ²² ÇÙ»ê½ÃÇè, ¸é¿ªÃøÁ¤ µî °¢ ºÐ¾ßÀÇ ½ÃÀ嵿Çâ°ú °æÇպм® ¹× 2006³âºÎÅÍ 2012³â±îÁöÀÇ ½ÃÀå¿¹Ãø µî¿¡ °üÇÏ¿© ´ë·« ¾Æ·¡¿Í °°Àº ±¸¼ºÀ¸·Î Á¦°øÇÕ´Ï´Ù.

    Á¦ 1 Àå °³¿ä
    Á¦ 2 Àå ¹Ì±¹ÀÇ ¾ÏÀ» À§ÇÑ Ã¼¿ÜÁø´Ü½ÃÀå Àüü
    • ½ÃÀå°³¿ä
      • ¼­·Ð
      • Á¶»ç¹æ¹ý
      • ½ÃÀå±â¼ú Æò°¡
      • ¼ö¿äºÐ¼®
      • ¾Ï ÇÁ·ÎÆÄÀÏ
    • ¼öÀÍ¿¹Ãø
      • ¹üÀ§¿Í ±¸ºÐ
      • ½ÃÀå ¿¹Ãø
    • ½ÃÀåÀÇ °úÁ¦¿Í Àü·«Àû Á¦¾ð
      • ¾÷°è°úÁ¦
      • Àü·«Àû Á¦¾ð
    • ½ÃÀåÀüüÀÇ ÃßÁø·Â°ú µ¿Çâ
      • ½ÃÀå ÃËÁøÀÎÀÚ
      • ½ÃÀå ÀúÇØÀÎÀÚ
      • ½ÃÀå ¹× ±â¼úµ¿Çâ
    • ½ÅÈï½ÃÀå : ´Ü¹éÁú ¾ÆÀÌ¼ÒÆû(Isoform) °Ë»ç
      • ¾ÆÀÌ¼ÒÆû Áø´ÜÀÇ µµÀÔ
    Á¦ 3 Àå ÇÙ»ê½ÃÇè¿¡ ÀÇÇÑ ¾ÏÁø´Ü½ÃÀå
    • °³¿ä
      • ¼­·Ð
      • ¹üÀ§¿Í ±¸ºÐ
      • ½ÃÀå±â¼ú Æò°¡
    • ½ÃÀå ÃËÁøÀÎÀÚ¿Í ÀúÇØÀÎÀÚ
    • ½ÃÀå¿¹Ãø°ú Á¦Ç°ºÐ¼®
    • °æÇպм®
      • °æÇÕȯ°æ
      • ½ÃÀå Á¡À¯À² ºÐ¼®
    Á¦ 4 Àå ¹Ì±¹ÀÇ ¸é¿ªÃøÁ¤¿¡ ÀÇÇÑ ¾ÏÁø´Ü½ÃÀå
    • °³¿ä
      • ¼­·Ð
      • ¹üÀ§¿Í ±¸ºÐ
      • ½ÃÀå±â¼ú Æò°¡
    • ½ÃÀå ÃËÁøÀÎÀÚ¿Í ÀúÇØÀÎÀÚ
    • ½ÃÀå¿¹Ãø°ú Á¦Ç°ºÐ¼®
    • °æÇպм®
      • °æÇÕȯ°æ
      • ½ÃÀå Á¡À¯À² ºÐ¼®
    Á¦ 5 Àå ¹Ì±¹ÀÇ ÃֽŠ¿°»ö¹ý¿¡ ÀÇÇÑ ¾ÏÁø´Ü½ÃÀå
    • °³¿ä
      • ¼­·Ð
      • ¹üÀ§¿Í ±¸ºÐ
      • ½ÃÀå±â¼ú Æò°¡
    • ½ÃÀåÃËÁøÀÎÀÚ¿Í ÀúÇØÀÎÀÚ
    • ½ÃÀå¿¹Ãø°ú Á¦Ç°ºÐ¼®
    • °æÇպм®
      • °æÇÕȯ°æ
      • ½ÃÀå Á¡À¯À² ºÐ¼®
    Á¦ 6 Àå ºÎ·Ï
    • ÀÇ»ç°áÁ¤Áö¿ø µ¥ÀÌÅͺ£À̽º
      • ¼¼°èÀÇ ¾Ï¹ßº´·ü
      • ¹æ±¤¾ÏÀÇ ¹ßº´·ü°ú »ç¸Á·ü
      • À¯¹æ¾ÏÀÇ ¹ßº´·ü°ú »ç¸Á·ü
      • °áÀåÁ÷Àå¾ÏÀÇ ¹ßº´·ü°ú »ç¸Á·ü
      • °£¾ÏÀÇ ¹ßº´·ü°ú »ç¸Á·ü
      • Æó¾ÏÀÇ ¹ßº´·ü°ú »ç¸Á·ü
      • Àü¸³¼±¾ÏÀÇ ¹ßº´·ü°ú »ç¸Á·ü
      • À§¾ÏÀÇ ¹ßº´·ü°ú »ç¸Á·ü
      • Èí¿¬ÀÚ¼ö¿Í ´ã¹è¼Òºñ·®
ksa
Back to Top